logo

For the Inventor, By the Inventor

Milford, MA, United States of America

Avecia Biotechnology, Inc.


USPTO Granted Patents = 19

% Expired Patents = 15.8



Trademarks = 3

Forward Citations = 179

Loading Chart...
Loading Chart...

22 inventors (with patents filed for the assignee):

goldMedal Nanda Dulal Sinha (8 out of 8 patents)

silverMedal Jin-Yan Tang (6 out of 17 patents)

bronzeMedal Paul McCormac (3 out of 3 patents)

4.  Satya Kuchimanchi (2 out of 2 patents)

5.  William Edward Zedalis (2 out of 2 patents)

6.  Gregory Keith Miranda (2 out of 2 patents)

7.  Donald Alfred Wellings (2 out of 7 patents)

8.  David John Moody (2 out of 2 patents)

9.  Zhaoda Zhang (2 out of 2 patents)

10.  Andrew Guy Livingston (1 out of 18 patents)

11.  Andrew Timothy Boam (1 out of 9 patents)

12.  Guangrong Zhang (1 out of 2 patents)

13.  Saied Shaikh (1 out of 1 patent)

14.  Dinesh Nair (1 out of 1 patent)

15.  Stephen Hargreaves (1 out of 1 patent)


19 patents:

1. 8193337 - Oxidation process (2012-06-05),
2. 8163891 - Process for the preparation of poly(alkoxylated) oligonucleotides (2012-04-24),
3. 8093397 - Activators for oligonucleotide synthesis (2012-01-10),
4. 7960542 - Process for purifying oligonucleotide synthons (2011-06-14),
5. 7872121 - Process for the removal of exocyclic base protecting groups (2011-01-18),
6. 7635772 - Process for the preparation of oligonucleotides (2009-12-22),
7. 7560555 - Process for the preparation of phosphitylation agents (2009-07-14),
8. 7501505 - Activators for oligonucleotide synthesis (2009-03-10),
9. 7476709 - Process for preparing oligonucleotides (2009-01-13),
10. 7365132 - Monomers containing polyoxyalkylenes and polymer supports therefrom (2008-04-29),
11. 7247720 - Phosphitylation process (2007-07-24),
12. 7230095 - Immobilization of oligonucleotides onto solid supports (2007-06-12),
13. 7038027 - Method of preventing modification of synthetic oligonucleotides (2006-05-02),
14. 6538128 - Detritylation solvents for nucleic acid synthesis (2003-03-25),
15. 6500944 - Sulfurizing reagent: 3-aryl-1,2,4-dithiazoline-5-ones (2002-12-31),
Company Overview
Avecia Biotechnology, Inc. is a prominent player in the biotechnology sector, specializing in the development and manufacturing of biologics and advanced therapeutic products. The company focuses on providing innovative solutions in areas such as protein production, gene therapy, and vaccine development. With a commitment to quality and regulatory compliance, Avecia serves a diverse range of clients, including pharmaceutical and biotechnology firms, primarily in the United States and beyond, contributing to advancements in healthcare and therapeutic technologies.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

19 Patents

#9 in Milford, MA

#1,049 in Massachusetts

#17,138 in US

#32,663 in the World

Milford, MA (US)
Milford, MA, United States of America

Avecia Biotechnology, Inc.

Forward Citations = 179

22 inventors:

goldMedal Nanda Dulal Sinha (8 out of 8 patents)

silverMedal Jin-Yan Tang (6 out of 17 patents)

bronzeMedal Paul McCormac (3 out of 3 patents)

4.  Satya Kuchimanchi (2 out of 2 patents)

5.  William Edward Zedalis (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Avecia Biotechnology, Inc.. Retrieved from https://idiyas.com/company/avecia-biotechnology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…